Definium Therapeutics
Tracked across 3 events · 44 articles · First seen Apr 13, 2026 · Last active Jul 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Definium Therapeutics issued inducement grants of stock options to newly hired non-executive employees, which is a common practice to attract and retain talent. This action could positively impact the company's ability to grow and develop new therapeutics.
Jun 01, 2026 · 10 articles
Business
Definium Therapeutics, a late-stage clinical biopharmaceutical company, announced the issuance of inducement stock options to newly hired non-executive employees. On July 6, 2026, options for 169,740 common shares were granted to eight employees, and on…
Impact: Definium Therapeutics issued inducement stock options to new employees as part of standard hiring practices. The event has no material effect on the company's operations or financials.
Jul 06, 2026 · 8 articles
International
Impact: Definium Therapeutics added 13.3% following Donald Trump's executive order on psychedelic drug research.
Apr 13, 2026 · 26 articles
20
Definium Therapeutics issued inducement grantsDefinium Therapeutics...
ERGEN INTELLIGENCE
Track Definium Therapeutics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard